| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SLC4A1 | GDSC1000 | pan-cancer | AAC | 0.3 | 4e-25 |
| mRNA | TRIM10 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-17 |
| mRNA | TSPO2 | GDSC1000 | pan-cancer | AAC | 0.25 | 8e-17 |
| mRNA | ACSBG1 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-13 |
| mRNA | CR1 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-13 |
| mRNA | TPSG1 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-11 |
| mRNA | SPTA1 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-11 |
| mRNA | HBM | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | GPT | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | AHSP | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
